Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof

CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof

US Patent 12161674 · Granted Dec 10, 2024

Estimated economic value: $673,523,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for editing beta-globin for treatment of hemaglobinopat2025
Materials and methods for treatment of hemoglobinopathies2025
Materials and methods for treatment of pain related disorders2025
Methods for therapeutic administration of messenger ribonucleic acid drugs2025
Materials and methods for treatment of hereditary haemochromatosis2025
Materials and methods for treatment of Duchenne Muscular Dystrophy2024
Materials and methods for treatment of hemoglobinopathies2024
Terminally modified RNA2024
Compositions and methods for gene editing2024
Materials and methods for treatment of glycogen storage disease type 1A2024
Materials and methods for treatment of alpha-1 antitrypsin deficiency2023
Materials and methods for treatment of pain related disorders2023